Consequently, the ALT/HDL-C ratio, which integrates hepatic injury and lipid metabolism, appears to be a robust indicator of the “typical” metabolic dysfunction driving NAFLD in middle-aged adults, but may be less sensitive to the more complex and heterogeneous pathophysiology in the elderly. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.